Piramal Pharma will host a conference call on April 29, 2026, to discuss Q4 and full-year FY2026 financial results.
The call is scheduled from 9:30 AM to 10:15 AM IST with global dial-in numbers provided for participants.
This intimation is made pursuant to Regulation 30(6) of the SEBI Listing Obligations and Disclosure Requirements.